Progress in the use of adeno-associated viral vectors for gene therapy

Cells Tissues Organs

Volumn 177, Issue 3, 2004, Pages 139-150

  Büning, Hildegard ^a   Braun Falco, Markus ^b   Hallek, Michael ^a,c,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adeno associated virus; Epidermis; Genodermatosis; Wound healing

Indexed keywords

ANTINEOPLASTIC AGENT; PARVOVIRUS VECTOR; PROTEASOME INHIBITOR; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

BIOLOGY; CELL DIVISION; CONFERENCE PAPER; DRUG SAFETY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INJECTION; KERATINOCYTE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; SEROTYPE; SKIN; VIRUS CAPSID; VIRUS PARTICLE;

ANIMALS; CELL DIVISION; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; KERATINOCYTES; ORGAN SPECIFICITY; RECOMBINANT PROTEINS; SEROTYPING; SKIN DISEASES; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; PARVOVIRUS;

EID: 4644273498     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079988     Document Type: Conference Paper

References (115)

1. Adams, J. (2002) Development of the proteasome inhibitor PS-341. Oncologist 7: 9-16.
2. Aumailley, M., M. Gerl, A. Sonnenberg, R. Deutzmann, R. Timpl (1990) Identification of the Arg-Gly-Asp sequence in laminin A chain as a latent cell-binding site being exposed in fragment P1. FEBS Lett 262: 82-86.
3. Balague, C., M. Kalla, W.W. Zhang (1997) Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol 71: 3299-3306.
4. Barrandon, Y., H. Green (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302-2306.
5. Bartlett, J.S., J. Kleinschmidt, R.C. Boucher, R.J. Samulski (1999) Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab′γ)2 antibody. Nat Biotechnol 17: 181-186.
6. Bartlett, J.S., R. Wilcher, R.J. Samulski (2000) Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 74: 2777-2785.
7. Blacklow, N.R. (1988) Adeno-associated virus of humans; in Pattison, J.R. (ed): Parvoviruses and Human Disease. Boca Raton, CRC Press, pp 165-174.
8. Blacklow, N.R., M.D. Hoggan, A.Z. Kapikian, J.B. Austin, W.P. Rowe (1968) Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 88: 368-378.
9. Blacklow, N.R., M.D. Hoggan, M.S. Sereno, C.D. Brandt, H.W. Kim, R.H. Parrot, R.M. Chanock (1971) A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol 94: 359-366.
10. Braun-Falco, M. (2002) Gene therapy concepts for promoting wound healing (in German). Hautarzt 53: 238-243.
11. Braun-Falco, M., A. Doenecke, H. Smola, M. Hallek (1999) Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors. Gene Ther 6: 432-441.
12. Braun-Falco, M., M. Hallek (1998) Cutaneous gene therapy - Perspectives of gene transfer in keratinocytes (in German). Hautarzt 49: 536-544.
13. Büning, H., M.U. Ried, L. Perabo, F.M. Gerner, N.A. Huttner, J. Enssle, M. Hallek (2003) Receptor targeting of adeno-associated virus vectors. Gene Ther 10: 1142-1151.
14. Carter, P.J., R.J. Samulski (2000) Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6: 17-27.
15. Cosset, F.L., S.J. Russell (1996) Targeting retrovirus entry. Gene Ther 3: 946-956.
16. Deodato, B., N. Arsic, L. Zentilin, M. Galeano, D. Santoro, V. Torre, D. Altavilla, D. Valdembri, F. Bussolino, F. Squadrito, M. Giacca (2002) Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 9: 777-785.
17. Descamps, V., N. Blumenfeld, Y. Beuzard, M. Perricaudet (1996) Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adeno-associated virus vector. Arch Dermatol 132: 1207-1211.
18. Ding, W., Z. Yan, R. Zak, M. Saavedra, D.M. Rodman, J.F. Engelhardt (2003) Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J Virol 77: 7361-7366.
19. Donahue, B.A., J.G. McArthur, S.K. Spratt, D. Bohl, C. Lagarde, L. Sanchez, B.A. Kaspar, B.A. Sloan, Y.L. Lee, O. Danos, R.O. Snyder (1999) Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med 1: 31-42.
20. Douar, A.M., K. Poulard, D. Stockholm, O. Danos (2001) Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J Virol 75: 1824-1833.
21. Duan, D., Q. Li, A.W. Kao, Y. Yue, J.E. Pessin, J.F. Engelhardt (1999) Dynamin is required for recombinant adeno-associated virus type 2 infection. J Virol 73: 10371-10376.
22. Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K.J. Fisher, J.F. Engelhardt (1998) Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 72: 8568-8577.
23. Duan, D., Y. Yue, Z. Yan, J.F. Engelhardt (2000a) A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat Med 6: 595-598.
24. Duan, D., Y. Yue, Z. Yan, J. Yang, J.F. Engelhardt (2000b) Endosomal processing limits gene transfer to polarized airway epithelia by adenoassociated virus. J Clin Invest 105: 1573-1587.
25. During, M.J., M.G. Kaplitt, M.B. Stern, D. Eidelberg (2001) Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 12: 1589-1591.
26. During, M.J., R.J. Samulski, J.D. Elsworth, M.G. Kaplitt, P. Leone, X. Xiao, J. Li, A. Freese, J.R. Taylor, R.H. Roth, J.R. Sladek Jr., K.L. O'Malley, D.E. Redmond Jr. (1998) In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 5: 820-827.
27. Dutheil, N., F. Shi, T. Dupressoir, R.M. Linden (2000) Adeno-associated virus site-specifically integrates into a muscle-specific DNA region. Proc Natl Acad Sci USA 97: 4862-4866.
28. Ferrari, F.K., X. Xiao, D. McCarty, R.J. Samulski (1997) New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nat Med 3: 1295-1297.
29. Flotte, T.R., P.L. Zeitlin, T.C. Reynolds, A.E. Heald, P. Pedersen, S. Beck, C.K. Conrad, L. Brass-Ernst, M. Humphries, K. Sullivan, R. Wetzel, G. Taylor, B.J. Carter, W.B. Guggino (2003) Phase I trial of intranasal and endobronchial administration of a recombinant adenoassociated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 14: 1079-1088.
30. Galeano, M., B. Deodato, D. Altavilla, D. Cucinotta, N. Arsic, H. Marini, V. Torre, M. Giacca, F. Squadrito (2003a) Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46: 546-555.
31. Galeano, M., B. Deodato, D. Altavilla, G. Squadrito, P. Seminara, H. Marini, F. Stagno d'Alcontres, M. Colonna, M. Calo, P. Lo Cascio, V. Torre, M. Giacca, F.S. Venuti, F. Squadrito (2003b) Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med 31: 1017-1025.
32. Gao, G., M.R. Alvira, S. Somanathan, Y. Lu, L.H. Vandenberghe, R. Calcedo, J. Sanmiguel, Z. Abbas, J.M. Wilson (2003) Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci USA 100: 6081-6086.
33. Gao, G.P., M.R. Alvira, L. Wang, R. Calcedo, J. Johnston, J.M. Wilson (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99: 11854-11859.
34. Giraud, C., E. Winocour, K.I. Berns (1994) Sitespecific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci USA 91: 10039-10043.
35. Girod, A., M. Ried, C. Wobus, H. Lahm, K. Leike, J. Kleinschimdt, G. Deleage, M. Hallek (1999) Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2. Nat Med 5: 1052-1056.
36. Goldman, R. (2004) Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care 17: 24-35.
37. Grifman, M, Trepel M, Speece P, L.B. Gilbert, W. Arap, R. Pasqualini, M.D. Weitzman (2001) Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. Mol Ther 3: 964-975.
38. Grimm, D., M.A. Kay, J.A. Kleinschmidt (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 7: 839-850.
39. Grimm, D., A. Kern, K. Rittner, J.A. Kleinschmidt (1998) Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 9: 2745-2760.
40. Grimm, D., J.A. Kleinschmidt (1999) Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther 10: 2445-2450.
41. Guy, J., X. Qi, N. Muzyczka, W.W. Hauswirth (1999) Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol 117: 929-937.
42. Halbert, C.L., J.M. Allen, A.D. Miller (2001) Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 75: 6615-6624.
43. Hansen, J., K. Qing, H.-J. Kwon, C. Mah, A. Srivastava (2000) Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol 74: 992-996.
44. Hauck, B., L. Chen, W. Xiao (2003) Generation and characterization of chimeric recombinant AAV vectors. Mol Ther 7: 419-425.
45. Hengge, U.R., A. Mirmohammadsadegh (2000) Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2: 188-194.
46. Herzog, R.W., E.Y. Yang, L.B. Couto, J.N. Hagstrom, D. Elwell, P.A. Fields, M. Burton, D.A. Bellinger, M.S. Read, K.M. Brinkhous, G.M. Podsakoff, T.C. Nichols, G.J. Kurtzman, K.A. High (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5: 56-63.
47. Hirata, R.K., D.W. Russell (2000) Design and packaging of adeno-associated virus gene targeting vectors. J Virol 74: 4612-4620.
48. Huttner, N.A., A. Girod, L. Perabo, D. Edbauer, J.A. Kleinschmidt, H. Buning, M. Hallek (2003a) Genetic modification of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther 10: 2139-2147.
49. Huttner, N.A., A. Girod, S. Schnittger, C. Schoch, M. Hallek, H. Büning (2003b) Analysis of sitespecific transgene integration following cotransduction with recombinant adeno-associated virus (rAAV) and a rep encoding plasmid. J Gene Med 5: 120-129.
50. Irvine, A.D., W.H. McLean (2003) The molecular genetics of the genodermatoses: progress to date and future directions. Br J Dermatol 148: 1-13.
51. Jones, P.H., F.M. Watt (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713-724.
52. Jooss, K., N. Chirmule (2003) Immunity to adenovirus and adeno-associated viral vectors: implication for gene therapy. Gene Ther 10: 955-963.
53. Kaludov, N., K.E. Brown, R.W. Walters, J. Zabner, J.A. Chiorini (2001) Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 75: 6884-6893.
54. Khavari, P.A., O. Rollman, A. Vahlquist (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252: 1-10.
55. Kim, J.P., K. Zhang, J.D. Chen, R.H. Kramer, D.T. Woodley (1994) Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem 269: 26926-26932.
56. Kotin, R.M., R.M. Linden, K.I. Berns (1992) Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 11: 5071-5078.
57. Kotin, R.M., M. Siniscalco, R.J. Samulski, X.D. Zhu, L. Hunter, C.A. Laughlin, S. McLaughlin, N. Muzyczka, M. Rocchi, K.I. Berns (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87: 2211-2215.
58. LaVail, M.M., D. Yasumura, M.T. Matthes, K.A. Drenser, J.G. Flannery, A.S. Lewin, W.W. Hauswirth (2000) Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci USA 97: 11488-11493.
59. Liu, X., F. Voulgaropoulou, R. Chen, P.R. Johnson, K.R. Clark (2000) Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Mol Ther 2: 394-403.
60. Lundqvist, K., A. Schmidtchen (2001) Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers. Br J Dermatol 144: 254-259.
61. Maass, G., C. Bogedain, U. Scheer, D. Michl, M. Hörer, M. Braun-Falco, M. Volkenandt, D. Schadendorf, C. Wendtner, E.-L. Winnacker, R. Kotin, M. Hallek (1998) Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction into primary epithelial cancer cells. Hum Gene Ther 9: 1049-1059.
62. Mah, C., K. Qing, B. Khuntirat, S. Ponnazhagan, X.-S. Wang, D.M. Kube, M.C. Yoder, A. Srivastava (1998) Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Virol 72: 9835-9843.
63. Manno, C.S., A.J. Chew, S. Hutchison, P.J. Larson, R.W. Herzog, V.R. Arruda, S.J. Tai, M.V. Ragni, A. Thompson, M. Ozelo, L.B. Couto, D.G.B. Leonard, F.A. Johnson, A. McClelland, C. Scallan, E. Skarsgard, A.W. Flake, M.A. Kay, K.A. High, B. Glader (2003) AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101: 2963-2972.
64. Marchese, C., M. Sorice, C. De Stefano, L. Frati, M.R. Torrisi (1997) Modulation of keratinocyte growth factor receptor expression in human cultured keratinocytes. Cell Growth Differ 8: 989-997.
65. Miller, A.D (1996) Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci USA 93: 11407-11413.
66. Moss, R.B., D. Rodman, L.T. Spencer, M.L. Aitken, P.L. Zeitlin, D. Waltz, C. Milla, A.S. Brody, J.P. Clancy, B. Ramsey, N. Hamblett, A.E. Heald (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125: 509-521.
67. Nakai, H., E. Montini, S. Fuess, T.A. Storm, M. Grompe, M.A. Kay (2003) AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat Genet 34: 297-302.
68. Nakai, H., S.R. Yant, T.A. Storm, S. Fuess, L. Meuse, M.A. Kay (2001) Extrachromosomal recombinant adeno-associated virus vector genomes are primary responsible for stable liver transduction in vivo. Virology 75: 6969-6976.
69. Nicklin S.A., A.H. Baker (2002) Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr Gene Ther 2: 273-293.
70. Nicklin, S.A., H. Büning, K.L. Dishart, M. de Alwis, A. Girod, U. Hacker, A.J. Tharsher, R.R. Ali, M. Hallek, A.H. Baker (2001) Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther 4: 174-181.
71. Ohno, K., K. Sawai, Y. Iijima, B. Levin, D. Meruelo (1997) Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol 15: 763-767.
72. Opie, S.R., K.H. Warrington Jr., M. Agbandje-McKenna, S. Zolotukhin, N. Muzyczka (2003) Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J Virol 77: 6995-7006.
73. Penel, N., J. Bonneterre (2003) Gene therapy of melanoma: review of published clinical trials. Rev Med Interne 24: 443-451.
74. Perabo, L., H. Büning, D.M. Kofler, M.U. Ried, A. Girod, C.M. Wendtner, J. Enssle, M. Hallek (2003) In vitro selection of viral vectors with modified tropism: the adeno-associated virus display. Mol Ther 8: 151-157.
75. Peus, D., L. Hamacher, M.R. Pittelkow (1997) EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentation. J Invest Dermatol 109: 751-756.
76. Pittelkow, M.R., P. Cook, G. Shipley, R. Derynck, R.I. Coffey (1993) Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ 4: 513-521.
77. Ponnazhagan, S, G. Mahendra, S. Kumar, J.A. Thompson, M. Castillas Jr. (2002) Conjugatebased targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J Virol 76: 12900-12907.
78. Ponnazhagan, S., P. Mukherjee, X.S. Wang, K. Qing, D.M. Kube, C. Mah, C. Kurpad, M.C. Yoder, E.F. Srour, A. Srivastava (1997) Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J Virol 71: 8262-8267.
79. Ponnazhagan, S., X.S. Wang, M.J. Woody, F. Luo, L.Y. Kang, M.L. Nallari, N.C. Munshi, S.Z. Zhou, A. Srivastava (1996) Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection. J Gen Virol 77: 1111-1122.
80. Qiao, C., J. Li, A. Skold, X. Zhang, X. Xiao (2002a) Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes. J Virol 76: 1904-1913.
81. Qiao, C., B. Wang, X. Zhu, J. Li, X. Xiao (2002b) A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines. J Virol 76: 13015-13027.
82. Qing, K., B. Khuntirat, C. Mah, D.M. Kube, X.-S. Wang, S. Ponnazhagan, S.Z. Zhou, V.J. Dwarki, M.C. Yoder, A. Srivastava (1998) Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J Virol 72: 1593-1599.
83. Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, A. Srivastava (1999) Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5: 71-77.
84. Rabinowitz, J.E., F. Rolling, C. Li, H. Conrath, W. Xiao, X. Xiao, R.J. Samulski (2002) Crosspackaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76: 791-801.
85. Rabinowitz, J.E., R.J. Samulski (2000) Building a better vector: the manipulation of AAV virions. Virology 278: 301-308.
86. Ried, M.U., A. Girod, K. Leike, H. Büning, M. Hallek (2002) Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors. J Virol 76: 4559-4566.
87. Rizzo, W.B., Z. Lin, G. Carney (2001) Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome. Chem Biol Interact 130-132: 297-307.
88. Russell, D.W., I.E. Alexander, A.D. Miller (1995) DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 92: 5719-5723.
89. Samulski, R.J., X. Zhu, X. Xiao, J.D. Brook, D.E. Housman, N. Epstein, L.A. Hunter (1991) Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 10: 3941-3950.
90. Sanlioglu, S., P.K. Benson, J. Yang, E.M. Atkinson, T. Reynolds, J.F. Engelhardt (2000) Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol 74: 9184-9196.
91. Sanlioglu, S., M.M. Monick, G. Luleci, G.W. Hunninghake, J.F. Engelhardt (2001) Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 1: 137-147.
92. Schnepp, B.C., K.R. Clark, D.L. Klemanski, C.A. Pacak, P.R. Johnson (2003) Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol 77: 3495-3504.
93. Seisenberger, G., M.U. Ried, T. Endress, H. Büning, M. Hallek, C. Bräuchle (2001) Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science 294: 1929-1932.
94. Shi, W., G.S. Arnold, J.S. Bartlett (2001) Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 12: 1697-1711.
95. Shi, W., J.S. Bartlett (2003) RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfateindependent cell entry mechanism. Mol Ther 7: 515-525.
96. Smith, A.D., R.F. Collaco, J.P. Trempe (2003) Enhancement of recombinant adeno-associated virus type 2-mediated transgene expression in a lung epithelial cell line by inhibition of the epidermal growth factor receptor. J Virol 77: 6394-6404.
97. Snyder, R.O., C.H. Miao, G.A. Patijn, S.K. Spratt, O. Danos, D. Nagy, A.M. Gown, B. Winther, L. Meuse, L.K. Cohen, A.R. Thompson, M.A. Kay (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16: 270-276.
98. Stilwell, J.L., R.J. Samulski (2003) Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 34: 148-150.
99. Summerford, C., J.S. Bartlett, R.J. Samulski (1999) AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5: 78-82.
100. Summerford, C., R.J. Samulski (1998) Membraneassociated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72: 1438-1445.
101. Sun, J.Y., V. Anand-Jawa, S. Chatterjee, K.K. Wong (2003) Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther 10: 964-976.
102. Sun, L., J. Li, X. Xiao (2000) Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med 6: 599-602.
103. Surosky, R.T., M. Urabe, S.G. Godwin, S.A. McQuiston, G.J. Kurtzman, K. Ozawa, G. Natsoulis (1997) Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol 71: 7951-7959.
104. Thomas, C.E., A. Ehrhardt, M.A. Kay (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4: 346-358.
105. Walter, W., U. Stein (1996) Cell type specific and inducible promotors for vectors in gene therapy as an approach for cell targeting. J Mol Med 74: 379-392.
106. Watt, F.M. (2000) Epidermal stem cells as targets for gene transfer. Hum Gene Ther 11: 2261-2266.
107. White, St.J., St.A. Nicklin, H. Büning, J. Brosnan, K. Leike, E.D. Papadakis, M. Hallek, A.H. Baker (2004). Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors. Circulation 109: 513-519.
108. Wu, P., W. Xiao, T. Conlon, J. Hughes, M. Agbandje-McKenna, T. Ferkol, T. Flotte, N. Muzyczka (2000) Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol 74: 8635-8647.
109. Xiao, X., J. Li, R.J. Samulski (1996) Efficient longterm gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70: 8098-8108.
110. Xiao, X., J. Li, R.J. Samulski (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72: 2224-2232.
111. Xie, Q., W. Bu, S. Bhatia, J. Hare, T. Somasundaram, A. Azzi, M.S. Chapman (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA 99: 10405-10410.
112. Yakobson, B., T.A. Hrynko, M.J. Peak, E. Winocour (1989) Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol 63: 1023-1030.
113. Yalkinoglu, A.O., R. Heilbronn, A. Burkle, J.R. Schlehofer, H. zur Hausen (1988) DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res 48: 3123-3129.
114. Yalkinoglu, A.O., H. Zentgraf, U. Hubscher (1991) Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification. J Virol 65:3175-3184.
115. Yang, Q., M. Mamounas, G. Yu, S. Kennedy, B. Leaker, J. Merson, F. Wong-Staal, M. Yu, J.R. Barber (1998) Development of novel cell surface CD34-targeted recombinant adeno-associated virus vectors for gene therapy. Hum Gene Ther 9: 1929-1937.